Angalbio's innovative drug development projects are based on the target deconvolution and verification technology platform developed by the R&D team, as well as the new drug targets and mode of actions discovered based on related platforms.

Angalbio's innovative drug development projects are based on the target deconvolution and verification technology platform developed by the R&D team, as well as the new drug targets and mode of actions discovered based on related platforms.

Using world-class modern technology to discover the mode of actions of Traditional Chinese herbal medicine, combined with modern technologies such as AI-aided drug screening and cell engineering, to develop the natural compound based innovative drugs and therapies for unmet medical needs.

Based on the new drug targets and mode of action discovered by the R&D team, Angalbio's R&D platform mainly focuses on developing the innovative drugs and therapies for the following disease areas, i.e. cancer, infectious, metabolic and neurodegenerative diseases.